66P-25871-21118
2 vaccinations
6 coded responses
12 check-ins
6 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 038 / NH
- Registered
- 2021-05-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-13
Dose 1 — Moderna
-
2021-05-11
Dose 2 — Moderna
-
2021-05-12
Registered in v-safe
-
2021-05-12
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: DizzyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-05-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-05-17
- 2021-05-20
-
2021-05-25
Survey response — day 14, dose 2MedDRA: Nasopharyngitis — Feeling: FairFree text: Cold symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-01
- 2021-06-08
-
2021-06-25
Survey response — day 42, dose 2MedDRA: Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Autoimmune issues over the past 3 weeksMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-25
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-30
Call successfulParticipant prefers to complete VAERS report online
-
2021-08-10
Survey response — 3 months, dose 2MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-10
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-12
-
2021-11-09
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Bad cold for past 2 weeksMedDRA releases: 2024-11 · check-in free text available
-
2021-11-09
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-11-11
-
2022-05-13
Survey response — 12 months, dose 2MedDRA: COVID-19, Delivery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: COVID, gave birthMedDRA releases: 2024-11 · check-in free text available
-
2022-05-13
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-05-16
- 2022-05-16
- 2022-05-16
-
2022-05-16
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-05-16
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-05-16
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-13 | Moderna | |
| 2 | 2021-05-11 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-25 | Successful 2021-06-30 |
Participant prefers to complete VAERS report online |
| 2021-08-10 | Successful 2022-05-16 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2021-11-09 | Successful 2022-05-16 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-05-13 | Successful 2022-05-16 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Dizzy
Release 8 — day 14, dose 2
Symptoms: Cold symptoms
Release 9 — day 42, dose 2
Symptoms: Autoimmune issues over the past 3 weeks
Release 9 — 3 months, dose 2
Symptoms: Pregnancy
Release 10 — 6 months, dose 2
Symptoms: Bad cold for past 2 weeks
Release 11 — 12 months, dose 2
Symptoms: COVID, gave birth
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release